Alpha-lipoic acid - the special antioxidant

Hyperglycemia, which often occurs in diabetes mellitus patients, causes increased production of free oxygen radicals that damage peripheral nerves.

Alpha-lipoic acid is a free-radical scavenger that catches damaging oxygen radicals both in aqueous and lipid soluble cell environments, thereby counteracting the sensory disorders of diabetic polyneuropathy.

Since our body can only absorb a very small quantity of alpha-lipoic acid through our diet like innards, an additional supply is recommended.

Thiogamma® contains the active ingredient alpha-lipoic acid that protects the nerve cell from damaging degradation products and free radicals, thus being able to improve nerve conductivity.

  • Therapeutic Indications
    Dysaesthesia in diabetic polyneuropathy.
  • Active Substance and Composition
    One injection bottle with 50 ml injection solution contains alpha-lipoic acid, meglumine salt 1167.7 mg (equals 600 mg alpha-lipoic acid).

    Alpha lipoic acid

    For further substances read the Patient information leaflet.
  • Dosage and Method of Application
    In case of severe dysaesthesia in diabetic polyneuropathy, the intravenous administration of 600 mg alpha-lipoic acid daily (equals 1 injection bottle Thiogamma® Turbo-Set) is recommended in adults.

    In the initial treatment phase the injection is administered intravenously over a period of 2-4 weeks. The intravenous administration should be carried out slowly, administering the content as a short infusion for at least 30 minutes. The infusion is administered directly out of the bottle, using a standard infusion set and the attached light protection bag. Since the active substance is light sensitive, the injection bottle should be removed from the folding box shortly before use. The minimum infusion duration of 30 minutes has to be ensured.

    For maintenance therapy 300-600 mg alpha-lipoic acid in oral dosage form is applied.
  • Package Sizes
    • 5 x 50 ml infusion solution and 5 light protection pouches, 5 IV needles und 5 IV administration sets Solution for Infusion - PZN 00921438
    • 10 x 50 ml infusion solution and 10 light protection pouches, 10 IV needles und 10 IV administration sets Solution for Infusion - PZN 00921444
    • 1 x 50 ml infusion solution and 1 light protection pouch Solution for Infusion - PZN 03645849 (Pur)
    • 10 x 50 ml infusion solution and 10 light protection pouches Solution for Infusion - PZN 00921450 (Pur)
  • Obligatory Text
    Thiogamma® Turbo-Set. Active substance: alpha-lipoic acid. Therapeutic indications: Dysaesthesia in diabetic polyneuropathy. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
  • Downloads

Related Products